Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  London Stock Exchange  >  Ashtead Group    AHT   GB0000536739


Delayed Quote. Delayed London Stock Exchange - 06/14 11:35:08 am
1949 GBp   -0.84%
06/13ASHTEAD GROUP PLC : annual earnings release
05/28ASHTEAD GROUP PLC : - Notice of Results
05/22Ferguson appoints former Ashtead boss Geoff Drabble as chairman
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

What's at stake for Europe Inc in a trade spat with Washington

share with twitter share with LinkedIn share with facebook
share via e-mail
05/14/2019 | 03:10am EDT
U.S. Trade Representative Lighthizer and EU Trade Commissioner Malmstrom take part in a meeting to discuss steel overcapacity in Brussels

LONDON (Reuters) - Europe's listed companies are expected to generate 1.2 trillion euros (£1.0 trillion) in revenue from the United States this year, highlighting what's at stake as global trade tensions grow and earnings and economic growth stall.

Analysts and investors say that based on revenues, European companies are more vulnerable to a dispute than their competitors in the United States.

U.S. President Donald Trump is due to decide by Saturday whether to impose duties on car imports, potentially posing another significant threat to global growth and denting Europe's prized auto sector.

Washington's renewed tensions with Beijing may distract Trump and delay a decision beyond the May 18 deadline, or he may crank up his protectionist push with a global trade war on two fronts.

Last month, he also threatened to impose tariffs on hundreds of European goods, from cheese to ski suits, worth $11 billion.

The impact on Europe's top firms could be profound -- with slowing economic growth and some countries like Italy struggling with bulging budget deficits, the region may not be as resilient to a prolonged dispute as China has so far proven.

In the past six months, the Chinese government has launched stimulus measures from tax cuts to boosting lending to shore up the world's No. 2 economy as the trade spat rumbles on.

"I'm much more concerned about trade for Europe than I am for China," said Christophe Donay, head of asset allocation at Pictet Wealth Management.

According to Europe's top asset manager Amundi Asset Management, U.S sales average about 20% of MSCI Europe companies' aggregate turnover, while European sales average about 14% of turnover for companies in MSCI's U.S. share index,

For an interactive version of the below graphic, click herehttps://tmsnrt.rs/2VGtZSu.


Typically, Europe's carmakers are considered particularly vulnerable to Trump's protectionism.

A 25% tariff could result in a 0.2-0.3 percentage point loss of export revenue and GDP for Germany, according to an analysis by Moody's. The United States accounts for 13% of Germany's car exports, the ratings agency has said.

Measured by revenue, there's a lot at stake for companies like Fiat Chrysler with $45.3 billion in U.S. revenues. But many, like Fiat, have their own U.S. production plants, sheltering them slightly from any outright tariffs.

For an interactive version of the below graphic, click herehttps://tmsnrt.rs/2LCr9KG.

Caroline Simmons, deputy head of the UK investment office of UBS Global Wealth Management, said she would expect the technology, energy and industrial sectors to be worst-hit by any further antagonism.

Average European company exposure to the United States in those sectors ranges from 10 to 20% in terms of sales, compared with 33% for healthcare.

UBS is underweight consumer discretionary in the euro zone, which includes autos, partly because of the trade tariffs.

"The market is nervous about it and last year (the U.S.-China spat) escalated more than people expected and the effect on the market was bigger than people had anticipated," she said.


Of pan-European STOXX 600 index companies, those in healthcare have the highest revenue exposure on average.

An analysis by Refinitiv based on companies' estimates of 2019 revenue shows they draw some 133.3 billion euros in revenue from the world's No. 1 economy and top drug market.

For an interactive version of the below chart, click herehttps://tmsnrt.rs/2WwCixg.

While healthcare has not been implicated in the tit-for-tat between Washington and Brussels so far, some investors worry about the potential fall-out from souring relations between the two economic powerhouses.

"As these sectors are in normal times regarded as defensive, they may doubly disappoint if the U.S. and Europe also engage in a tariff war," said Ibra Wane, equity strategist at Amundi, in a note this week.

The European healthcare index has risen 8% since the late December low, underperforming most other industries and lagging behind an 11% rise in the benchmark STOXX 600.

Pharma and medical equipment companies from BTG to BB Biotech and Fresenius Medical Care are among the most exposed individual companies, with 67-90% of total sales derived from the United States.

Capital goods companies Ashtead and Ferguson are also high up on the list, with more than 80% of their sales made to the United States.

(Reporting by Josephine Mason and Ritvik Carvalho; Graphics by Ritvik Carvalho; Editing by Catherine Evans)

By Josephine Mason and Ritvik Carvalho

Stocks mentioned in the article
ChangeLast1st jan.
ASHTEAD GROUP -0.84% 1949 Delayed Quote.19.06%
BB BIOTECH AG -0.30% 65.85 Delayed Quote.12.76%
BTG PLC 0.00% 834.5 Delayed Quote.0.54%
FERGUSON PLC -1.00% 5566 Delayed Quote.10.94%
FIAT CHRYSLER AUTOMOBILES -0.47% 11.84 End-of-day quote.-6.64%
FRESENIUS MEDICAL CARE 0.66% 66.7 Delayed Quote.17.76%
STOXX EUROPE 600 -0.40% 378.81 Delayed Quote.12.19%
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on ASHTEAD GROUP
06/13ASHTEAD GROUP PLC : annual earnings release
05/28ASHTEAD GROUP PLC : - Notice of Results
05/22Ferguson appoints former Ashtead boss Geoff Drabble as chairman
05/14What's at stake for Europe Inc in a trade spat with Washington
05/08ASHTEAD : BridgeHead Software appoints David Moysen as Director of IT; Proven IT..
05/07LONDON STOCK EXCHANGE : U.S.-China trade concerns weigh on FTSE 100
05/01ASHTEAD : Directorate Changes
04/08London's blue-chips end higher, aided by oil majors
03/14ASHTEAD : Transaction in Own Shares
03/05LONDON STOCK EXCHANGE : GVC, weak pound lift FTSE 100; profit-taking hits Intert..
More news
Financials (GBP)
Sales 2019 4 433 M
EBIT 2019 1 250 M
Net income 2019 808 M
Debt 2019 3 491 M
Yield 2019 1,91%
P/E ratio 2019 11,60
P/E ratio 2020 9,91
EV / Sales 2019 2,84x
EV / Sales 2020 2,56x
Capitalization 9 119 M
Duration : Period :
Ashtead Group Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ASHTEAD GROUP
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 23,9  GBP
Spread / Average Target 22%
EPS Revisions
Geoffrey Drabble Chief Executive Officer & Executive Director
Paul Ashton Walker Chairman
Brendan Horgan Chief Operating Officer & Executive Director
Michael Pratt Finance Director, Treasurer & Executive Director
Lucinda Jane Riches Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
ASHTEAD GROUP19.06%10 933
AIR LEASE CORP28.57%4 046